Philips’ revenues contraction in the first quarter of 2022 was less than feared and its order book remains impressive, but challenges presented by the recall program and generic post-COVID factors for the year ahead remain substantial.
The dip in Philips' first-quarter sales ̶ down 4% year-over-year to €3.9bn ($4.2bn) ̶ was not as sharp as the high-single digits drop projected in earlier guidance but reflects the tough set of business circumstances the company faces, according to CEO Frans van Houten
Chief among these challenges is the ongoing recall associated with Respironics’ ventilators, announced in 2021. Extrapolating current trends in...
Finland has initiated a project to improve the effectiveness of the monitoring of software intended for medical use and to ensure that software placed on its market meets the requirements set for it.
The Milner Institute, the on-campus hub for start-up acceleration at Cambridge University, hosted its annual Pitch Day on July 1. Start-ups Panakeia, PathwayBio and Sentinal4D presented diagnostic technologies.
To succeed in medtech, investors must focus on patient outcomes. Gilde Healthcare says involving patients boosts product effectiveness, access and market success — making it a smart strategy in today’s strained healthcare systems.
